Tevogen Bio Holdings Inc (NASDAQ:TVGN)’s traded shares stood at 3.61 million during the last session, with the company’s beta value hitting -1.26. At the close of trading, the stock’s price was $1.07, to imply an increase of 5.94% or $0.06 in intraday trading. The TVGN share’s 52-week high remains $21.09, putting it -1871.03% down since that peak but still an impressive 75.7% since price per share fell to its 52-week low of $0.26. The company has a valuation of $198.43M, with an average of 1.42 million shares in intraday trading volume over the past 10 days and average of 16.49 million shares over the past 3 months.

Tevogen Bio Holdings Inc (NASDAQ:TVGN) trade information

After registering a 5.94% upside in the last session, Tevogen Bio Holdings Inc (TVGN) has traded red over the past five days. The 5-day price performance for the stock is 11.38%, and -28.72% over 30 days. With these gigs, the year-to-date price performance is -90.39%. Short interest in Tevogen Bio Holdings Inc (NASDAQ:TVGN) saw shorts transact 3.69 million shares and set a 0.09 days time to cover.

TVGN Dividends

Tevogen Bio Holdings Inc has its next earnings report out in January. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

We also have Fidelity Small Cap Index Fund and iShares Russell 2000 Growth ETF as the top two Mutual Funds with the largest holdings of the Tevogen Bio Holdings Inc (TVGN) shares. Going by data provided on Aug 31, 2024 , Fidelity Small Cap Index Fund holds roughly 207.17 shares. This is just over 0.12% of the total shares, with a market valuation of $0.22 million. Data from the same date shows that the other fund manager holds a little less at 145.9, or 0.08% of the shares, all valued at about 0.16 million.